Ironwood Pharmaceuticals (IRWD) Convertible Debt (2015 - 2025)
Ironwood Pharmaceuticals (IRWD) posted Convertible Debt of $199.2 million for Q1 2025, little changed sequentially from $199.0 million in Q4 2024, and little changed YoY from $198.5 million in Q1 2024.
Ironwood Pharmaceuticals (IRWD) Convertible Debt (2015 - 2025) Analysis & Trends
Ironwood Pharmaceuticals has reported Convertible Debt for 11 years, with the latest figure at $199.2 million in Q1 2025.
- Quarterly Convertible Debt changed 0.34% year-over-year to $199.2 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $199.2 million (changed 0.34% YoY) and the FY2024 annual result came in at $199.0 million, changed 0.34% from the prior year.
- Convertible Debt was little changed at $199.2 million in Q1 2025 per IRWD's latest filing, from $199.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $436.1 million in Q1 2021 and troughed at $198.0 million in Q2 2023.
- A 5-year average of $294.3 million and a median of $329.2 million in 2021 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2022 and 2024: Convertible Debt advanced 20.14% in 2022, then sank 49.96% in 2024.
- Over 5 years, Convertible Debt stood at $337.3 million in 2021, then gained by 17.47% to $396.3 million in 2022, then plunged by 49.95% to $198.3 million in 2023, then climbed by 0.34% to $199.0 million in 2024, then grew by 0.09% to $199.2 million in 2025.
- According to Business Quant data, Convertible Debt over the past three periods registered $199.2 million, $199.0 million, and $198.8 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 199.16 Mn |
| Dec 31, 2024 | 198.99 Mn |
| Sep 30, 2024 | 198.82 Mn |
| Jun 30, 2024 | 198.65 Mn |
| Mar 31, 2024 | 198.48 Mn |
| Dec 31, 2023 | 198.31 Mn |
| Sep 30, 2023 | 198.14 Mn |
| Jun 30, 2023 | 197.97 Mn |
| Mar 31, 2023 | 396.65 Mn |
| Dec 31, 2022 | 396.25 Mn |
| Sep 30, 2022 | 395.85 Mn |
| Jun 30, 2022 | 395.45 Mn |
| Mar 31, 2022 | 395.05 Mn |
| Dec 31, 2021 | 337.33 Mn |
| Sep 30, 2021 | 333.21 Mn |
| Jun 30, 2021 | 329.16 Mn |
| Mar 31, 2021 | 436.08 Mn |
| Dec 31, 2020 | 430.26 Mn |
| Sep 30, 2020 | 424.54 Mn |
| Jun 30, 2020 | 418.92 Mn |